New version of CIEL concept dictionary added to dropbox

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for July 5, 2021!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0!

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for COVID-19, PIH and KenyaEMR. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release.


concept_id name Class Datatype description
166533 Pharyngotonsillitis Diagnosis N/A \N
166532 World Health Organization Partograph ConvSet N/A \N
166531 Pitocin drip dose (drops/min) Question Numeric \N
166531 Oxytocin drip dose (drops/min) Question Numeric \N
166530 Pitocin concentration (U/L) Question Numeric \N
166530 Oxytocin concentration (U/L) Question Numeric \N
166529 Frequency of uterine contractions within 10 minute period Question Numeric \N
166528 Descent of fetal head in relation to ischial spines Question Numeric Proportion of head above spines out of 5
166527 Fetal moulding score Question Coded \N
166527 Degree of foetal moulding Question Coded \N
166526 Alcohol and Drug Abuse Assessment screening results Question Coded \N
166525 Personal life ambitions Question Text \N
166525 Personal life ambitions (text) Question Text \N
166524 PASP (pulmonary artery systolic pressure) Question Numeric \N
166524 sPAP Question Numeric \N
166524 Pulmonary artery systolic pressure (mmHg) Question Numeric \N
166523 Infection due to B.1.617.2 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Diagnosis N/A \N
166523 Infection due to Delta variant COVID-19 Diagnosis N/A \N
166523 Infection due to COVID-19 B.1.617.2 Diagnosis N/A \N
166522 3TC + DRV/r + RAL + TDF Misc N/A ARV regimen
166522 Darunavir / Lamivudine / Raltegravir / Ritonavir / Tenofovir Misc N/A ARV regimen
166522 3TC/DRV/RAL/RTV/TDF Misc N/A ARV regimen
166521 3TC + DTG + DRV/r + TDF Misc N/A ARV regimen
166521 Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir Misc N/A ARV regimen
166521 3TC/DAL/DRV/DTG/RTV Misc N/A ARV regimen
166520 Ended pregnancy since last visit Question Coded \N
166520 Terminated pregnancy since last visit Question Coded \N
166519 Screening not done Finding N/A \N
166519 Screening not performed Finding N/A \N
166518 Ineligible for screening Finding N/A \N
166518 Screening not needed Finding N/A \N
166517 Shares drug injecting equipment Finding N/A \N
166517 Shares needles and/or syringes Finding N/A \N
166516 Unreliable condom use Finding N/A Person uses condoms for sex either inconsistently or never at all.
166515 Referred for family planning services Procedure Coded \N
166514 Misuses drugs other than intravenously Finding N/A \N
166514 Non-intravenous drug user Finding N/A \N
166513 Female prostitute Misc N/A \N
166513 Female sex worker Misc N/A \N
166512 Peer educator Finding Coded \N
166511 Description of physical abuse Question Text \N
166510 Year began injecting drugs Question Numeric Calendar year when person began injecting drugs
166510 Year started IVDU Question Numeric Calendar year when person began injecting drugs
166509 Year man started having sex with men Question Numeric The first year that a male starting having sex with other men.
166508 Year started sex work Question Numeric The calendar year that the person began having sex for payment.
166507 Consent given to contact partner Finding Coded \N
166506 Name of sexual partner Question Text \N
166505 Has regular sex partner Question Coded Patient has a regular partner for sexual activity
166504 Number of IVDU per week Question Numeric Average number of drug injections per week
166504 Number of drug injection episodes per week Question Numeric Average number of drug injections per week
166503 Number of drug injection times per day Question Numeric \N
166503 Number of IVDU per day Question Numeric \N
166502 Number of anal sex acts per week Question Numeric \N
166501 Number of sex acts per week Question Numeric Average number of any form of sexual activity per week
166500 Name of transmission hotspot Question Text Name of location where disease transmission is likely to occur.
166499 Barber shop/beauty salon Misc N/A \N
166498 Strip club Misc N/A \N
166497 Brothel Misc N/A \N
166496 Hotel Misc N/A \N
166495 Massage parlor Misc N/A \N
166495 Massage parlour Misc N/A \N
166494 Drinking bar Misc N/A Drinking bar without lodging
166493 Drinking bar with lodging Misc N/A
166493 Hotel bar Misc N/A
166492 Casino Misc N/A \N
166491 Beach Misc N/A \N
166490 Public park Misc N/A \N
166489 Derelict building Misc N/A \N
166489 Uninhabitable building Misc N/A \N
166488 On the street Misc N/A Location or environment
166488 In the street Misc N/A Location or environment
166487 Treatment adherence plan Question Text \N
166486 Patient benefited from home visit Question Coded \N
166485 Patient experience with referral (text) Question Text \N
166484 Patient attended last scheduled appointment Question Coded \N
166483 Patient treated differently upon disclosure of health status Finding Coded \N
166482 Patient concerned about accidental disclosure of health status Finding Coded \N
166482 Patient worried about accidental disclosure of health status Finding Coded \N
166481 B.1.617.2 variant Misc N/A Spike: T19R, (G142D), 156del, 157del, R158G, L452R, T478K, D614G, P681R, D950N India variant
166481 Delta variant Misc N/A Spike: T19R, (G142D), 156del, 157del, R158G, L452R, T478K, D614G, P681R, D950N India variant
166480 B.1.429 variant Misc N/A S13I, W152C, L452R, D614G California variant
166479 B.1.427 variant Misc N/A L452R, D614G California variant
166478 Resolved Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Diagnosis N/A \N
166478 Resolved post-COVID-19 syndrome Diagnosis N/A \N
1 Like